95,136 Shares in Chemed Corporation $CHE Purchased by Caisse de depot et placement du Quebec

Caisse de depot et placement du Quebec acquired a new stake in shares of Chemed Corporation (NYSE:CHE) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 95,136 shares of the company’s stock, valued at approximately $44,309,000.

A number of other institutional investors have also bought and sold shares of CHE. Commonwealth Equity Services LLC boosted its holdings in shares of Chemed by 3.1% during the 4th quarter. Commonwealth Equity Services LLC now owns 734 shares of the company’s stock worth $314,000 after purchasing an additional 22 shares during the last quarter. Cim LLC increased its holdings in shares of Chemed by 1.1% in the third quarter. Cim LLC now owns 2,139 shares of the company’s stock valued at $958,000 after purchasing an additional 24 shares during the last quarter. Eukles Asset Management lifted its position in Chemed by 0.4% during the fourth quarter. Eukles Asset Management now owns 6,056 shares of the company’s stock worth $2,591,000 after buying an additional 25 shares in the last quarter. MassMutual Private Wealth & Trust FSB lifted its position in Chemed by 65.3% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 81 shares of the company’s stock worth $38,000 after buying an additional 32 shares in the last quarter. Finally, EverSource Wealth Advisors LLC boosted its stake in Chemed by 9.4% during the first quarter. EverSource Wealth Advisors LLC now owns 406 shares of the company’s stock worth $153,000 after buying an additional 35 shares during the last quarter. 95.85% of the stock is owned by hedge funds and other institutional investors.

Chemed Stock Down 5.1%

Shares of NYSE:CHE opened at $520.34 on Friday. The company has a market capitalization of $6.80 billion, a price-to-earnings ratio of 26.13, a PEG ratio of 2.08 and a beta of 0.51. Chemed Corporation has a 12-month low of $365.20 and a 12-month high of $557.00. The business has a 50-day moving average price of $507.71 and a 200 day moving average price of $449.15. The company has a current ratio of 0.91, a quick ratio of 0.89 and a debt-to-equity ratio of 0.17.

Chemed (NYSE:CHE) last posted its earnings results on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, beating analysts’ consensus estimates of $5.60 by $0.46. The company had revenue of $673.25 million for the quarter, compared to analysts’ expectations of $665.04 million. Chemed had a net margin of 10.60% and a return on equity of 31.77%. Chemed’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $4.27 earnings per share. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Sell-side analysts expect that Chemed Corporation will post 23.18 EPS for the current year.

Chemed Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Shareholders of record on Monday, August 17th will be paid a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a yield of 0.5%. This is a positive change from Chemed’s previous quarterly dividend of $0.60. The ex-dividend date is Monday, August 17th. Chemed’s payout ratio is currently 14.06%.

Insider Transactions at Chemed

In other news, Director Andrea R. Lindell sold 1,347 shares of the firm’s stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the transaction, the director directly owned 4,578 shares in the company, valued at $2,047,876.74. This trade represents a 22.73% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Spencer S. Lee sold 1,000 shares of the firm’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $541.04, for a total value of $541,040.00. Following the transaction, the executive vice president owned 13,912 shares of the company’s stock, valued at $7,526,948.48. This trade represents a 6.71% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 6,537 shares of company stock valued at $3,406,014 over the last three months. 3.33% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of analysts have issued reports on the company. Weiss Ratings raised Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 17th. Royal Bank Of Canada upped their price objective on shares of Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a report on Thursday, July 30th. Bank of America reaffirmed a “neutral” rating on shares of Chemed in a research note on Wednesday, July 29th. Wall Street Zen raised shares of Chemed from a “hold” rating to a “strong-buy” rating in a research note on Saturday, August 1st. Finally, Oppenheimer raised their price target on shares of Chemed from $500.00 to $590.00 and gave the stock an “outperform” rating in a report on Friday, July 31st. One equities research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, Chemed currently has an average rating of “Hold” and an average price target of $530.75.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.